BHVN
Biohaven Ltd.
NYSE · Healthcare · Biotechnology · US
$11.35
+5.29%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-4801.5%
Return on equity
-158.3%
Return on assets
-183.5%
Return on invested capital
0.00x
Asset turnover
-$511.4M
Cash from operations
$1.77
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026